These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects. Basal E, Jain A, Kaushal GP. J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305 [Abstract] [Full Text] [Related]
28. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. O'Neill AM, Gallo RL. Microbiome; 2018 Oct 02; 6(1):177. PubMed ID: 30285861 [Abstract] [Full Text] [Related]
29. Pathogenesis of acne. Toyoda M, Morohashi M. Med Electron Microsc; 2001 Mar 02; 34(1):29-40. PubMed ID: 11479771 [Abstract] [Full Text] [Related]
30. Antibiotic-resistant acne: lessons from Europe. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Peréz Del Pulgar JI, Rollman O, Török L, Eady EA, Cove JH. Br J Dermatol; 2003 Mar 02; 148(3):467-78. PubMed ID: 12653738 [Abstract] [Full Text] [Related]
31. Acne vulgaris: an investigation into the number of anaerobic diphtheroids and members of the Micrococcaceae in normal and acne skin. Holland KT, Cunliffe WJ, Roberts CD. Br J Dermatol; 1977 Jun 02; 96(6):623-6. PubMed ID: 141301 [Abstract] [Full Text] [Related]
32. Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant. Bellew S, Thiboutot D, Del Rosso JQ. J Drugs Dermatol; 2011 Jun 02; 10(6):582-5. PubMed ID: 21637898 [Abstract] [Full Text] [Related]
33. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Jahns AC, Lundskog B, Ganceviciene R, Palmer RH, Golovleva I, Zouboulis CC, McDowell A, Patrick S, Alexeyev OA. Br J Dermatol; 2012 Jul 02; 167(1):50-8. PubMed ID: 22356121 [Abstract] [Full Text] [Related]
34. Acne, the Skin Microbiome, and Antibiotic Treatment. Xu H, Li H. Am J Clin Dermatol; 2019 Jun 02; 20(3):335-344. PubMed ID: 30632097 [Abstract] [Full Text] [Related]
35. A comparison of culture and PCR methods for identifying Propionibacterium acnes in lesions isolated from patients with acne. Naghdi N, Ghane M. Turk J Med Sci; 2017 Jun 12; 47(3):967-972. PubMed ID: 28618752 [Abstract] [Full Text] [Related]
36. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris]. Ergin C, Kaleli I, Sahin R, Ergin S, Kaçar N. Mikrobiyol Bul; 2006 Jun 12; 40(1-2):15-21. PubMed ID: 16775952 [Abstract] [Full Text] [Related]
37. Quantification of bacteria in isolated pilosebaceous follicles in normal skin. Puhvel SM, Reisner RM, Amirian DA. J Invest Dermatol; 1975 Dec 12; 65(6):525-31. PubMed ID: 127814 [Abstract] [Full Text] [Related]
38. Propionibacterium acnes: an update on its role in the pathogenesis of acne. Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, Dreno B. J Eur Acad Dermatol Venereol; 2014 Mar 12; 28(3):271-8. PubMed ID: 23905540 [Abstract] [Full Text] [Related]
39. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine®. Pécastaings S, Roques C, Nocera T, Peraud C, Mengeaud V, Khammari A, Dréno B. J Eur Acad Dermatol Venereol; 2018 Jun 12; 32 Suppl 2():15-23. PubMed ID: 29894577 [Abstract] [Full Text] [Related]
40. Skin barrier and microbiome in acne. Rocha MA, Bagatin E. Arch Dermatol Res; 2018 Apr 12; 310(3):181-185. PubMed ID: 29147769 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]